Skip to main content

Kevin Winthrop, MD: H. zoster and tofacitinib: the risk of concomitant nonbiologic therapy

Nov 12, 2015 9:59 am

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×